Abstract
Background: Type 1 neurofibromatosis occurs in 1 in every 3,000 individuals, representing 90% of cases of neurofibromatosis. Hearing impairments are not commonly described as an alteration resulting from the pathology; however, sensorineural hearing losses with retrocochlear characteristics may...